mecamylamine and oxazoles

mecamylamine has been researched along with oxazoles in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dajas-Bailador, FA; Mogg, AJ; Wonnacott, S1
D'Aniello, E; Damaj, MI; Di Marzo, V; Donvito, G; Giordano, C; Guida, F; Ignatowska-Jankowska, BM; Jackson, A; Lichtman, AH; Maione, S; Mechoulam, R; Muldoon, P; Mustafa, MA; Parker, L; Petrie, GN; Piscitelli, F; Sim-Selley, L; Smoum, R; Vitale, RM1

Other Studies

2 other study(ies) available for mecamylamine and oxazoles

ArticleYear
Intracellular Ca2+ signals evoked by stimulation of nicotinic acetylcholine receptors in SH-SY5Y cells: contribution of voltage-operated Ca2+ channels and Ca2+ stores.
    Journal of neurochemistry, 2002, Volume: 81, Issue:3

    Topics: Aniline Compounds; Calcium; Calcium Channels; Calcium Signaling; Enzyme Inhibitors; Fluorescent Dyes; Humans; Intracellular Fluid; Macrocyclic Compounds; Mecamylamine; Neuroblastoma; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oxazoles; Receptors, Nicotinic; Ryanodine; Tumor Cells, Cultured; Xanthenes

2002
N-Oleoyl-glycine reduces nicotine reward and withdrawal in mice.
    Neuropharmacology, 2019, Volume: 148

    Topics: Animals; Brain Injuries, Traumatic; Cerebral Cortex; Conditioning, Classical; Glycine; Male; Mecamylamine; Mice; Nicotine; Oleic Acids; Oxazoles; PPAR alpha; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tyrosine

2019